News Column

Dyadic International To Present At World Bio Markets

March 3, 2014

By a News Reporter-Staff News Editor at Pharma Business Week -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, announced that its President and CEO, Mark Emalfarb, will be discussing enzymes, catalysts and microorganisms that reduce the cost of advanced biofuels at the World Bio Markets exhibition at The RAI, Amsterdam, Netherlands during its Panel Discussion: Reducing the Cost of Advanced Biofuels at 2:00 p.m. local time on March 5, 2014 (see also Dyadic International, Inc.).

All attendees of the World Bio Markets are invited to visit Dyadic's stand located at Booth #E102 where Dyadic's leading scientists and management will be available to discuss specific applications of Dyadic's CMAX™ enzymes designed for biofuel, bio-based chemical and bio gas applications. Dyadic's industry leading CMAX™ enzymes are highly customizable, scalable and extremely robust: operating at broad temperature and pH ranges.

The World Bio Markets is Europe's largest cross-value chain networking event and one of the bioproduct industry's premier events, supporting the world's development and search for alternative energy sources.

Keywords for this news article include: Biotechnology, Energy, Biofuel, Oil and Gas, Bioengineering, Enzymes and Coenzymes, Dyadic International Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Pharma Business Week

Story Tools